The commerce ministry has recommended continuation of anti-dumping duty for five years on a chemical used in pharma and agro industries, imported from the European Union and the US.
The move is aimed at guarding domestic manufacturers of 'Methylene Chloride' from cheap imports from the European Union (EU) and the US.
Continuation of the duty was recommended by the ministry's investigation arm Directorate General of Trade Remedies (DGTR), which conducted a probe into the alleged dumping of the chemical from these two regions.
In its findings, DGTR concluded that there is a "continued dumping" of the product from the EU and the US and that is causing injury to domestic industry here.
Despite the anti-dumping duty in force, the financial performance of the domestic industry has deteriorated, DGTR said in a notification.
"The authority recommends continued imposition of anti-dumping duty...for a period of five years concerning all imports of the subject goods originating in or exported from the EU and the US," it said.
It also concluded that during the period of investigation (January-December 2017), the domestic industry has shown negative growth in terms of the economic parameters such as production, sales, and profitability.
"The dumped imports from the EU and the US continue to cause injury to the domestic industry," it added.
Gujarat Fluorochemicals and Chemplast Sanmar had
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
